Janssen R&D BE
Why I'm a JPAL
I am a JPAL because I am passionate about bringing compounds from discovery into further development. I am an enthusiastic mentor, team-builder and net-worker with a passion for science.
Olivia is principal scientist within Infectious Diseases department of Janssen Pharmaceuticals NV (Johnson & Johnson), located in Beerse. Olivia Goethals received her Bachelor and Master's degree in bio-engineering from the university of Leuven in 2003. In 2004 she received an additional Master's degree in business economics. She joined Tibotec BVBA (currently Janssen Pharmaceuticals NV) in 2004 focusing on HIV entry inhibitors. In 2007 she started her PhD within the HIV integrase team in collaboration with the KULeuven. Four years later, Olivia obtained her PhD entitled: ‘Molecular mechanisms of viral resistance against HIV-1 inhibitors and integrase dimerization as a novel target for HIV-therapy’. In 2011, Olivia was appointed as the biology lead of the HIV peptide fusion project. Next, Olivia took up the role of biology project leader of the dengue project. In the beginning of 2018, Olivia initiated the Pan-Flavivirus project, from which she is currently still the biology project leader. At the end of 2019, Olivia got increased responsibilities as the discovery disease area lead of Global Public Health related projects within ID&V for both the emerging diseases discovery projects and tuberculosis discovery project. In 2019 Olivia received the Philip B. Hofmann Research Scientist Award (J&J).
"The bigger the dream, the more important the team!"
I was a tennis teacher in a former life.